Oncodesign Precision Medicine (ALOPM)

Last close As at 16/06/2025

EUR0.32

0.01 (1.61%)

Market capitalisation

EUR6m

Oncodesign Precision Medicine (OPM) is a biopharmaceutical company specialised in precision medicine for the treatment of resistant and metastatic cancers.

Sector

Healthcare

Equity Analyst

Jyoti Prakash

Jyoti Prakash, CFA

Director, healthcare

Key Management

  • Philippe Genne

    CEO

  • Karine Lignel

    COO

Thematics

thematic

Healthcare

Healthcare-focused trusts: A sector on the mend

thematic

Healthcare

Deutsches Eigenkapitalforum (EKF) 2023 healthcare

volition01

thematic

Healthcare

VolitionRx – Decoding the DNA of cancer 

Subscribe to Edison

Get access to the very latest content matched to your personal investment style.

Sign up for free